• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TrkA中激活环酪氨酸的酸性取代支持不依赖神经生长因子的细胞存活和神经元分化。

Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-independent cell survival and neuronal differentiation.

作者信息

Gryz E A, Meakin S O

机构信息

Neurodegeneration Group, The John P. Robarts Research Institute, London, Ontario, Canada.

出版信息

Oncogene. 2000 Jan 20;19(3):417-30. doi: 10.1038/sj.onc.1203330.

DOI:10.1038/sj.onc.1203330
PMID:10656690
Abstract

TrkA is the receptor tyrosine kinase (RTK) for nerve growth factor (NGF) and stimulates NGF-dependent cell survival and differentiation in primary neurons. TrkA expression in neuronal tumors also supports NGF-dependent differentiation of neuroblastomas and apoptosis of medulloblastomas. Phosphorylation of the activation loop tyrosines in RTK's are essential to activation as well as allosteric changes that facilitate substrate interaction and phosphorylation. Acidic amino acid substitution of the activation loop tyrosines in TrkA, Tyr683Tyr684, was performed to mimic the negative charges normally induced by ligand activation and receptor phosphorylation. A total of eight independent mutants containing single or double substitutions were generated for comparison. Herein, we demonstrate that acidic substitution of the activation loop tyrosines is sufficient to induce allosteric changes required for constitutive TrkA kinase activity as well as phosphorylation of TrkA signaling proteins such as Shc, PLCgamma-1, FRS-2 and erk1/2. The strongest constitutively active TrkA mutants, GluAsp and AspGlu, support NGF-independent neuritogenesis and cell survival to levels approximately 65 and 80-100%, respectively, of NGF-activated wild type TrkA. Thus, constitutively active TrkA may provide a useful strategy in future therapeutic approaches to limit the development and progression of neuronal tumors.

摘要

TrkA是神经生长因子(NGF)的受体酪氨酸激酶(RTK),可刺激原代神经元中NGF依赖的细胞存活和分化。TrkA在神经元肿瘤中的表达也支持神经母细胞瘤的NGF依赖分化和成神经管细胞瘤的凋亡。RTK激活环酪氨酸的磷酸化对于激活以及促进底物相互作用和磷酸化的变构变化至关重要。对TrkA激活环酪氨酸Tyr683Tyr684进行酸性氨基酸替换,以模拟通常由配体激活和受体磷酸化诱导的负电荷。总共产生了八个包含单取代或双取代的独立突变体用于比较。在此,我们证明激活环酪氨酸的酸性替换足以诱导组成型TrkA激酶活性所需的变构变化以及TrkA信号蛋白(如Shc、PLCγ-1、FRS-2和erk1/2)的磷酸化。最强的组成型活性TrkA突变体GluAsp和AspGlu分别支持NGF非依赖的神经突生长和细胞存活,达到NGF激活的野生型TrkA水平的约65%和80 - 100%。因此,组成型活性TrkA可能为未来限制神经元肿瘤发生和进展的治疗方法提供一种有用的策略。

相似文献

1
Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-independent cell survival and neuronal differentiation.TrkA中激活环酪氨酸的酸性取代支持不依赖神经生长因子的细胞存活和神经元分化。
Oncogene. 2000 Jan 20;19(3):417-30. doi: 10.1038/sj.onc.1203330.
2
Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.TrkA中激活环酪氨酸的酸性取代支持人神经母细胞瘤细胞系SY5Y中神经生长因子依赖性而非神经生长因子非依赖性的分化和细胞周期停滞。
Oncogene. 2003 Nov 27;22(54):8774-85. doi: 10.1038/sj.onc.1206890.
3
Nerve growth factor induces a multimeric TrkA receptor complex in neuronal cells that includes Crk, SHC and PLC-gamma 1 but excludes P130CAS.神经生长因子在神经元细胞中诱导形成一种多聚体TrkA受体复合物,该复合物包括Crk、SHC和PLC-γ1,但不包括P130CAS。
Oncogene. 1996 Jan 4;12(1):77-86.
4
SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.SHP-1作为一种TrkA磷酸酶发挥作用,对神经元存活起负向调节作用。
J Cell Biol. 2003 Dec 8;163(5):999-1010. doi: 10.1083/jcb.200309036.
5
Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.抑制Abl酪氨酸激酶可通过改变信号复合物和受体周转来增强神经生长因子介导的Bcr-Abl转化细胞中的信号传导。
Oncogene. 2008 Aug 7;27(34):4678-89. doi: 10.1038/onc.2008.107. Epub 2008 Apr 21.
6
Redox regulation of nerve growth factor-induced neuronal differentiation of PC12 cells through modulation of the nerve growth factor receptor, TrkA.通过调节神经生长因子受体TrkA对神经生长因子诱导的PC12细胞神经元分化的氧化还原调节。
Arch Biochem Biophys. 2005 Feb 1;434(1):16-25. doi: 10.1016/j.abb.2004.07.036.
7
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.信号特异性受体酪氨酸激酶癌蛋白的使用表明,Grb2或Shc下游的信号通路足以导致细胞转化和转移。
Oncogene. 2002 Mar 14;21(12):1800-11. doi: 10.1038/sj.onc.1205261.
8
Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.神经生长因子对人胰腺癌细胞的生长具有不同的作用。
Clin Cancer Res. 2001 Jan;7(1):105-12.
9
A nerve growth factor-induced retrograde survival signal mediated by mechanisms downstream of TrkA.一种由TrkA下游机制介导的神经生长因子诱导的逆行存活信号。
Neuropharmacology. 2007 Feb;52(2):270-8. doi: 10.1016/j.neuropharm.2006.07.032. Epub 2006 Sep 1.
10
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.通过FRS2的表皮生长因子受体(EGFR)和成纤维细胞生长因子受体(FGFR)信号传导受细胞外调节蛋白激酶1/2(ERK1/2)的负反馈控制。
Biol Chem. 2003 Aug;384(8):1215-26. doi: 10.1515/BC.2003.134.

引用本文的文献

1
Crystal structure and functional implication of the RUN domain of human NESCA.人 NESCA 的 RUN 结构域的晶体结构和功能意义
Protein Cell. 2012 Aug;3(8):609-17. doi: 10.1007/s13238-012-2052-3. Epub 2012 Jul 22.
2
Interaction of Mint2 with TrkA is involved in regulation of nerve growth factor-induced neurite outgrowth.Mint2与TrkA的相互作用参与了神经生长因子诱导的神经突生长的调控。
J Biol Chem. 2009 May 1;284(18):12469-79. doi: 10.1074/jbc.M809214200. Epub 2009 Mar 5.
3
Differentiation of neuroblastoma cell line N1E-115 involves several signaling cascades.
神经母细胞瘤细胞系N1E-115的分化涉及多个信号级联反应。
Neurochem Res. 2005 Mar;30(3):333-48. doi: 10.1007/s11064-005-2607-2.
4
Trafficking of TrkA-green fluorescent protein chimerae during nerve growth factor-induced differentiation.在神经生长因子诱导分化过程中TrkA-绿色荧光蛋白嵌合体的运输
J Biol Chem. 2003 Mar 7;278(10):8706-16. doi: 10.1074/jbc.M202401200. Epub 2002 Nov 15.